Pharmacological treatment of men with atrial fibrillation, April 2001 to March 2002
| Treatment | Age group, n (%) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| <45 years | 45–54 years | 55–64 years | 65–74 years | 75–84 years | >85 years | <75 years | ⩾75 years | All ages | ||
| (n = 42) | (n = 126) | (n = 305) | (n = 539) | (n = 532) | (n = 137) | (n = 1012) | (n = 669) | (n = 1681) | ||
| CCB, calcium-channel blocker. | ||||||||||
| *Excluding dihydropyridines. | ||||||||||
| †Includes quinidine, disopyramide, propafenone and flecainide. | ||||||||||
| ‡Warfarin or aspirin or clopidogrel. | ||||||||||
| §β-Blocker or rate-limiting CCB or digoxin. | ||||||||||
| ¶Class 1 antiarrhythmic or amiodarone or sotalol. | ||||||||||
| β-Blocker | 12 (28.6) | 46 (36.5) | 107 (35.1) | 181 (33.6) | 139 (26.1) | 13 (9.5) | 346 (34.2) | 152 (22.7) | 498 (29.6) | |
| CCBs* | 17 (40.5) | 67 (53.2) | 153 (50.2) | 262 (48.6) | 206 (38.7) | 23 (16.8) | 499 (49.3) | 229 (34.2) | 728 (43.3) | |
| Digoxin | 2 (11.1) | 33 (26.2) | 112 (36.7) | 216 (40.1) | 223 (41.9) | 73 (53.5) | 363 (35.9) | 296 (44.2) | 659 (39.2) | |
| Class I antiarrhythmics† | 2 (4.8) | 6 (4.8) | 16 (5.2) | 15 (2.8) | 9 (1.7) | 0 (0) | 39 (3.9) | 9 (1.3) | 48 (2.9) | |
| Amiodarone | 5 (11.9) | 17 (13.5) | 49 (16.1) | 64 (11.9) | 56 (10.5) | 11 (8.0) | 135 (13.3) | 67 (10.0) | 202 (12.0) | |
| Sotalol | 3 (7.1) | 10 (7.9) | 26 (8.5) | 30 (5.6) | 26 (4.9) | 2 (1.5) | 69 (6.8) | 28 (4.2) | 97 (5.8) | |
| Warfarin | 10 (23.8) | 43 (34.1) | 146 (47.9) | 292 (54.2) | 238 (44.7) | 37 (27.0) | 491 (48.5) | 275 (41.1) | 766 (45.6) | |
| Aspirin | 6 (14.3) | 32 (25.4) | 114 (37.4) | 209 (38.8) | 275 (51.7) | 79 (57.7) | 361 (35.7) | 354 (52.9) | 715 (42.5) | |
| Clopidogrel | 0 (0.0) | 3 (2.4) | 2 (0.7) | 21 (3.9) | 14 (2.6) | 4 (2.9) | 26 (2.6) | 18 (2.7) | 44 (2.6) | |
| Any antithrombotic‡ | 14 (33.3) | 64 (50.8) | 223 (73.1) | 451 (83.7) | 452 (85.0) | 110 (80.3) | 752 (74.3) | 562 (84.0) | 1314 (78.2) | |
| Negative chronotropes§ | 18 (42.9) | 82 (65.1) | 213 (69.8) | 389 (72.2) | 365 (68.6) | 86 (62.8) | 702 (69.4) | 451 (67.4) | 1153 (68.6) | |
| Any antiarrhythmic¶ | 10 (23.8) | 31 (24.6) | 84 (27.5) | 105 (19.5) | 91 (17.1) | 13 (9.5) | 230 (22.7) | 104 (15.5) | 334 (19.9) | |